Laurea Magistrale (Second cycle degree/Two year Master - 120 ECTS) in Medical Biotechnology

Degree programme

Programme type Laurea Magistrale (Second cycle degree/Two year Master - 120 ECTS)
Academic Year 2017/2018
General policies and regulations D.M. 270
Code 8859
Course class LM-9 - Pharmaceutical, Veterinary and Medical biotechnologies.
Years in which the programme is being held I, II
Mode of study Convenzionale
Admission typology Open access with assessment of personal competencies
Place of teaching Bologna
Degree Type Only few courses provide joint degree
Inter-University programme UNIVERSIDAD DE OVIEDO
Programme Director Irene Faenza
Teachers Teachers
Language Italian

Admission requirements and assessment of previously acquired knowledge/competences

Admission Requirements

The programme offers the possibility to obtain a dual degree with the University of Oviedo (Spain) based on a specific agreement.

To be able to profitably complete the 2nd cycle degree programme in Medical Biotechnologies, candidates must have university-level knowledge of:

- Normal Human Morphology: molecular cytology, tissue structure, organs and apparatus from macroscopic to ultrastructural levels;

- Human Physiology: cell, organ and apparatus functions;

- Biochemistry and Molecular Biology: structural, cellular and molecular biochemistry, enzymology and clinical biochemistry;

- Human pathology: molecular bases and phenotypic features of pathological processes;

- Genetics: Mendelian, classic, human and molecular.

Curricular requirements:

1. A 1st cycle degree in one of the following classes, or other suitable qualification obtained abroad:

ex Italian Ministerial Decree no. 270:

- Class L-2 Biotechnologies

- Class L-13 Biological Sciences

- Class LM-41 Medicine and Surgery

ex. Italian Ministerial Decree no. 509/99:

- Class 1 Biotechnologies

- Class 12 Biological Sciences

- Class 46S Medicine and Surgery

Previous five-year system degree in Biological Sciences and in Biotechnologies.

2. At least 40 CFU credits in one or more of the following scientific-disciplinary fields:

- BIO/09 Physiology

- BIO/13 Applied Biology

- BIO/14 Pharmacology

- BIO/16 Human Anatomy

- BIO/17 Embriology

- MED/04 General Pathology

- MED/05 Clinical Pathology

- MED/07 Microbiology

- FIS/01 - FIS/08

- BIO/10

Candidates not meeting the above requirements will be interviewed by a board to assess their possession of the required knowledge and skills.

The Board, appointed by the Degree Programme Board, will establish a calendar for the interviews, which will be published on the University Portal. If the Board considers the level of the candidates' knowledge and skills to be satisfactory, they will be allowed to enrol in a test to assess their personal competencies and skills.

Candidates must also have a command of the English language to level B1.

The Degree Programme may require students to recover any initial deficit in their language skills if they are assessed to below level B1 on admission.

According to a specific agreement, students of the University of Oviedo opting to spend year II at the University of Bologna on the Medical Biotechnologies programme must have obtained 5 CFU in Human Anatomy in their 1st cycle studies and have English language certification to level B2.

Assessment of personal competencies and skills

Admission to the 2nd cycle degree programme is subject to the possession of the described curricular requirements and the assessment of personal competencies and skills, the methods of which will be published on the University portal.

A special Admissions session may be held for international students, with a Board appointed to assess the candidates' personal competencies and skills; this session will be compatible with the schedule established in the call for applications for study grants (which indicatively expires in May).

For students of the Spanish university, personal competencies and skills are assessed by a Board of the Partner university, according to the inter-university agreement.

The degree programme may have restricted access, depending on the available resources.

The number of places and selection methods are published annually in the relative call for applications.

Personal competencies and skills are deemed to be accepted for all candidates achieving at least the minimum score, laid down in the call for applications for restricted access, in the entrance exam.

Programme profile

This content is not currently available

Expected learning outcomes

Specific learning outcomes of the Programme

The 2nd cycle degree programme in Medical Biotechnologies aims to produce professionals with high level skills in scientific, technical and productive planning and development of applied biotechnologies in the field of human health, and who can therefore work in positions of high responsibility. At the end of the two year programme, Medical Biotechnology graduates will have acquired the knowledge and technical skills to work professionally in the following fields:

- Experimentation and coordination of research projects and activities in the biomedical field, experimentation of drugs for advanced treatments and tissue engineering products;

- Prevention and diagnosis, through the management of molecular analysis and biomedical technologies;

- Treatments focusing particularly on the development and experimentation of innovative biotechnological medicines and systems (including gene therapy and regenerative medicine) applied to human pathology;

- Development of patents and evaluation or the relative industrial application in the biomedical field considering the ethical, technical, legal implications as well as environmental impact.

- Ability to dialogue with the international teaching community to foster the adoption of Biotechnologies in the global market;

- Management of the ethical and European regulatory aspects of new biotechnological health products (regenerative medicine and gene therapy) for humans.

They will also have acquired the learning skills required to continue specialist studies, e.g. 2nd level Master's programmes, PhD programmes and Specialisation schools.

Having passed the state examination, they may also register with the professional register of biologists.

The proposed study programme produces Medical Biotechnologists whose professional skills can be applied above all in the more conventional areas of research in both the public and private sector, as well as in the healthcare sector.

The increasingly urgent demands of the biotechnology industry led to this cooperation with the University of Oviedo, Spain, and a review of the degree programme in order to train Medical Biotechnologists with specific managerial skills. Italian students on the programme may choose an international curriculum, the first year spent in Bologna and the second year studying a managerial curriculum at the University of Oviedo, Spain. Vice versa, in line with the signed agreement, Spanish students on the Master's programme in Biotechnology of Environment and Health, spend the first year in Orviedo and then the second year studying the medical curriculum in Bologna. The degree is issued by each University according to the agreement.

The reviewed study programme therefore has three curricula:

a) a traditional study programme;

b) a managerial curriculum (only for year II for Italian students, spent at the partner university in Spain);

b) a clinical-medical curriculum (only for year II for Spanish students, spent at the University of Bologna).

In line with the identified professional figures, the learning outcomes of the degree programme focus mainly on the following subject areas:

- ANATOMY, PHYSIOLOGY AND BIOCHEMICAL, MOLECULAR AND GENETIC BASES OF HUMAN PATHOLOGY

- LABORATORY DIAGNOSTICS

- BIOMOLECULAR BASES OF ORGAN PATHOLOGIES AND INNOVATIVE MEDICAL TREATMENTS

- MANAGEMENT IN BIOTECHNOLOGIES AND BIOTECHNOLOGICAL INNOVATION FOR HUMAN HEALTH

Access to further study

It gives access to third cycle studies (Dottorato di ricerca/Scuole di specializzazione) and master universitario di secondo livello.

Career opportunities

Medical Biotechnologist

function in a professional context:

Medical biotechnologists apply biotechnological knowledge to advance medical science; they participate in the development of innovative drugs, medicines and diagnostic treatments using biotechnological processes, products deriving from cell and tissue engineering, focusing on the needs of patients and their families.

Medical Biotechnologists perform the following functions with high-level responsibility:

- Experimentation and coordination of biomedical research projects, participating particularly in the experimentation of innovative medicines, drugs for advanced treatments in the field of gene therapy, cell therapy and tissue engineering;

- Participation in a multidisciplinary team, planning and defining prevention and diagnosis interventions, managing molecular analysis and biomedical technologies;

- Participation in the evaluation of individually targeted interventions based on genetic tests and genomic drugs;

- Participation in therapeutic approaches focusing particularly on the development and experimentation of innovative biotechnological medicines and systems (including gene therapy and regenerative medicine) applied to human pathology.

- Participation in working groups to draft regulations concerning the technical and scientific aspects of identifying new therapeutic principles, drafting patents and assessing their industrial application in the biomedical field;

- Monitoring of clinical trials or acting as Clinical Research Associate (CRA) in different treatment areas in compliance with the relative procedures;

- Managerial or strategic consulting roles in the biotechnology field, promoting the culture of innovation and technology transfer to the business world.

To gain greater levels of autonomy and responsibility, Medical Biotechnology graduates may acquire further competences through 2nd level professional master's programmes in the field of business management, or may continue their studies to PhD or specialisation school level.

competencies associated to the function:

To perform the above described functions, specific knowledge is required of basic and applied science as well as specific competences in the field of biomedicine and genetic engineering. Graduates must also be able to conduct basic and applied biotechnological research, with specialist practical skills in the health and management fields.

In addition to these competences, graduates must have an inclination for lifelong learning, and possess transversal communication and interpersonal skills, according to the assigned level of autonomy and responsibility, organising and working effectively with all stakeholders (colleagues, other professions, users and patients).

career opportunities:

The main career opportunities in Italy and abroad:

- Public and private research bodies and universities.

- National Health Service and private healthcare facilities

- Biotechnologies industries and services

- Pharmacovigilance bodies

- Food and nutrition industry

- Environmental Prevention agencies

- Supervisory bodies

- Medical examiner

- Diagnostics and Pharmaceutics industry

- Biotech industry

- Notified and certification bodies

- National and international regulatory authorities

- CRA or Clinical Monitor (CM)

- Patents offices

- Technology Transfer companies

- Publishing and scientific communication companies

- Management consulting and/or savings management companies (Venture Capital)

- Charities

- Sector associations (scientific, industrial, patients)

- Institutions (Ministry of Health)

Further studies:

- PhD/doctoral programme

- Specialisation school

- Professional Master's Programmes

- for Clinical Research Associate,CRA: certification in compliance with DM of 15 November 2011;

Having passed the state examination, they may also register with the professional register of biologists (Senior list).

Contact details

Coordinator of the degree programme

Prof.ssa Irene Faenza

E-mail: irene.faenza2@unibo.it

Student AdministrationOffice of the Faculty of Medicine and Surgery
E-mail: segmed@unibo.it
Telephone: 051/2094601